國立虎尾科技大學 |

Ubiquitin Chains: Degradation and Beyond

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Ubiquitin Chains: Degradation and Beyond/ by Arnab De.
Author:	De, Arnab.
Description:	XV, 103 p. 45 illus., 33 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Proteins . -
Online resource:	https://doi.org/10.1007/978-3-319-14965-3
ISBN:	9783319149653

Ubiquitin Chains: Degradation and Beyond
De, Arnab.

Ubiquitin Chains: Degradation and Beyond[electronic resource] /by Arnab De. - 1st ed. 2015. - XV, 103 p. 45 illus., 33 illus. in color.online resource. - Springer Theses, Recognizing Outstanding Ph.D. Research,2190-5053. - Springer Theses, Recognizing Outstanding Ph.D. Research,.

1 Immune homeostasis: Activation and Downregulation of NF-κB -- 2 Regulation of NF-κB signaling by regulatory ubiquitination: specific pathways and A20 -- 3 The deubiquitinase activity of A20 is dispensable for its role in NF-κB signaling -- 4 Perspectives on regulatory ubiquitination.

This thesis examines the evidence for regulatory ubiquitination by focusing on A20. It provides an insightful and in-depth evaluation of the current literature by critically examining the evidence of K63-linked regulatory ubiquitination in regulating cell-signalling. It is also the first thesis to directly test the role of regulatory ubiquitination in NF-kB signaling in vivo. The case for regulatory ubiquitination has been to a large extent predicated upon the presumed deubiquitinase activity of A20, long considered a key regulator of inflammatory responses as mice lacking A20 die from multi-organ inflammation and cachexia. The theses reports the creation and characterization of a knock-in mouse that expresses a mutated form of A20 which selectively lacks the deubiquitinase activity. The knock-in mice surprisingly display completely normal NF-κB activation with no accompanying inflammatory phenotype. Given that the presumed role of A20 as a deubiquitinase has been used to support the importance of regulatory K63-linked ubiquitination in NF-kB signaling, this study will help focus future research efforts into alternative target pathways that do not depend on K63 ubiquitination. In fact, the work suggests that it might be important to revisit the role of K63-linked polyubiquitination in cell-signalling. Ubiquitin Chains: Degradation and Beyond is essential reading for anyone conducting research in cell-signalling and immunology. Dr. Arnab De received his PhD from the Department of Microbiology & Immunology at Columbia University. During his PhD, he developed transgenic mice to study the mechanism of action of a critical tumor-suppressor called A20. He is also well known for having developed peptide-based prodrugs as therapeutics for diabetes. His work has been reported by the media, and has resulted in multiple patents and publications in peer reviewed journals. He presented his findings at the American Peptide Symposium and was awarded the Young Investigator’s Award. He is the author of the book entitled Application of Peptide-Based Prodrug Chemistry in Drug Development, with a foreword written by Professor Jean Martinez (Former President, European Peptide Society) and published in the series SpringerBriefs in Pharmaceutical Science & Drug Development. His research interests lie at the intersection of chemistry and medicine. Besides biomedical research, he is also generally interested in public health policy and general scientific outreach.

ISBN: 9783319149653

Standard No.: 10.1007/978-3-319-14965-3doiSubjects--Topical Terms:

1253493
Proteins .

LC Class. No.: QD431-431.7

Dewey Class. No.: 572.6

Ubiquitin Chains: Degradation and Beyond
LDR:04209nam a22004095i 4500 001 968840
003 DE-He213
005 20200630183749.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319149653 $9 978-3-319-14965-3
024 7 $a 10.1007/978-3-319-14965-3 $2 doi
035 $a 978-3-319-14965-3
050 4 $a QD431-431.7
072 7 $a PSBC $2 bicssc
072 7 $a SCI007000 $2 bisacsh
072 7 $a PSB $2 thema
082 0 4 $a 572.6 $2 23
100 1 $a De, Arnab. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1021977
245 1 0 $a Ubiquitin Chains: Degradation and Beyond $h [electronic resource] / $c by Arnab De.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a XV, 103 p. 45 illus., 33 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Springer Theses, Recognizing Outstanding Ph.D. Research, $x 2190-5053
505 0 $a 1 Immune homeostasis: Activation and Downregulation of NF-κB -- 2 Regulation of NF-κB signaling by regulatory ubiquitination: specific pathways and A20 -- 3 The deubiquitinase activity of A20 is dispensable for its role in NF-κB signaling -- 4 Perspectives on regulatory ubiquitination.
520 $a This thesis examines the evidence for regulatory ubiquitination by focusing on A20. It provides an insightful and in-depth evaluation of the current literature by critically examining the evidence of K63-linked regulatory ubiquitination in regulating cell-signalling. It is also the first thesis to directly test the role of regulatory ubiquitination in NF-kB signaling in vivo. The case for regulatory ubiquitination has been to a large extent predicated upon the presumed deubiquitinase activity of A20, long considered a key regulator of inflammatory responses as mice lacking A20 die from multi-organ inflammation and cachexia. The theses reports the creation and characterization of a knock-in mouse that expresses a mutated form of A20 which selectively lacks the deubiquitinase activity. The knock-in mice surprisingly display completely normal NF-κB activation with no accompanying inflammatory phenotype. Given that the presumed role of A20 as a deubiquitinase has been used to support the importance of regulatory K63-linked ubiquitination in NF-kB signaling, this study will help focus future research efforts into alternative target pathways that do not depend on K63 ubiquitination. In fact, the work suggests that it might be important to revisit the role of K63-linked polyubiquitination in cell-signalling. Ubiquitin Chains: Degradation and Beyond is essential reading for anyone conducting research in cell-signalling and immunology. Dr. Arnab De received his PhD from the Department of Microbiology & Immunology at Columbia University. During his PhD, he developed transgenic mice to study the mechanism of action of a critical tumor-suppressor called A20. He is also well known for having developed peptide-based prodrugs as therapeutics for diabetes. His work has been reported by the media, and has resulted in multiple patents and publications in peer reviewed journals. He presented his findings at the American Peptide Symposium and was awarded the Young Investigator’s Award. He is the author of the book entitled Application of Peptide-Based Prodrug Chemistry in Drug Development, with a foreword written by Professor Jean Martinez (Former President, European Peptide Society) and published in the series SpringerBriefs in Pharmaceutical Science & Drug Development. His research interests lie at the intersection of chemistry and medicine. Besides biomedical research, he is also generally interested in public health policy and general scientific outreach.
650 0 $a Proteins . $3 1253493
650 0 $a Cell cycle. $3 787710
650 0 $a Immunology. $3 592892
650 1 4 $a Protein Science. $3 782127
650 2 4 $a Cell Cycle Analysis. $3 883879
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319149660
776 0 8 $i Printed edition: $z 9783319149646
776 0 8 $i Printed edition: $z 9783319385341
830 0 $a Springer Theses, Recognizing Outstanding Ph.D. Research, $x 2190-5053 $3 1253569
856 4 0 $u https://doi.org/10.1007/978-3-319-14965-3
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)